newsfilter
← Latest News
GlobeNewswire·

Large Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation

BEVERLY, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), an innovative, molecular diagnostics company that has commercialized the MiQLab®